Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5818)
All Articles published online
|
Publishing Process of This Article
|
Jan 21, 2015 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xi ZF, Xia Q. Recent advances in prevention of hepatitis B recurrence after liver transplantation. World J Gastroenterol 2015; 21(3): 829-835 [PMID: 25624716 DOI: 10.3748/wjg.v21.i3.829] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i3/829.htm |
| Number | Citing Articles |
| 1 |
Eva Maria Teegen, Max Magnus Maurer, Brigitta Globke, Johann Pratschke, Dennis Eurich. Liver transplantation for Hepatitis‐B‐associated liver disease ‐ Three decades of experience. Transplant Infectious Disease 2019; 21(1) doi: 10.1111/tid.12997
|
| 2 |
Kimberly Brown. Maximizing donors with viral hepatitis in the current era. Liver Transplantation 2017; 23(S1): S44 doi: 10.1002/lt.24863
|
| 3 |
N. Lim, S. Jackson, C. Engler, J.R. Lake. The Impact of Tenofovir Disoproxil Fumarate on Reduced Bone Mineral Density and Fractures in Liver Transplant Recipients. Transplantation Proceedings 2021; 53(1): 215 doi: 10.1016/j.transproceed.2020.09.009
|
| 4 |
Xie Man, Rao Wei. Advancements in the prevention of hepatitis B recurrence by nucleos(t)ide analogue monotherapies after liver transplantation. European Journal of Inflammation 2022; 20 doi: 10.1177/1721727X221139254
|
| 5 |
Bin Lou, Guanghua Ma, Feifei LV, Quan Yuan, Fanjie Xu, Yuejiao Dong, Sha Lin, Yajun Tan, Jie Zhang, Yu Chen. Baseline Quantitative Hepatitis B Core Antibody Titer Is a Predictor for Hepatitis B Virus Infection Recurrence After Orthotopic Liver Transplantation. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.710528
|
| 6 |
Shirin Demma, Emmanouil Tsochatzis, Geoffrey Dusheiko. Expansion of Access to HBV Treatment. Current Hepatology Reports 2015; 14(3): 195 doi: 10.1007/s11901-015-0272-8
|
| 7 |
Arno Kornberg. Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation. World Journal of Hepatology 2015; 7(11): 1494-1508 doi: 10.4254/wjh.v7.i11.1494
|
| 8 |
Zhuo-Lun Song, Yu-Jun Cui, Wei-Ping Zheng, Da-Hong Teng, Hong Zheng. Application of nucleoside analogues to liver transplant recipients with hepatitis B. World Journal of Gastroenterology 2015; 21(42): 12091-12100 doi: 10.3748/wjg.v21.i42.12091
|
| 9 |
Di Lu, Jianyong Zhuo, Modan Yang, Chao Wang, Linhui Pan, Haiyang Xie, Xiao Xu, Shusen Zheng. The association between donor genetic variations in one-carbon metabolism pathway genes and hepatitis B recurrence after liver transplantation. Gene 2018; 663: 121 doi: 10.1016/j.gene.2018.03.071
|
| 10 |
Hong-Shiue Chou, Chih-Hsien Cheng, Hao-Chien Hung, Jin-Chiao Lee, Yu-Chao Wang, Tsung-Han Wu, Chen-Fang Lee, Ting-Jung Wu, Kun-Ming Chan, Wei-Chen Lee. Significance of Hepatitis B Recurrence in Liver Transplantation Recipients. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/2489526
|